Calliari Luis Eduardo, Cudizio Laura, Tschiedel Balduino, Pedrosa Hermelinda C, Rea Rosangela, Pimazoni-Netto Augusto, Hirsch Laurence, Strauss Kenneth
1Pediatric Endocrine Unit, Department of Pediatrics, Santa Casa de Sao Paulo School of Medical Sciences, Sao Paulo, SP Brazil.
2Pediatric Endocrine Unit, Department of Pediatrics, Santa Casa de Sao Paulo, Sao Paulo, SP Brazil.
Diabetol Metab Syndr. 2018 Nov 27;10:85. doi: 10.1186/s13098-018-0389-3. eCollection 2018.
In 2014-2015, the largest international survey of insulin injection technique in patients with diabetes taking insulin was conducted in 42 countries, totaling 13,289 participants. In Brazil, patients from five public health centers were included. This study aims to evaluate insulin injection technique in Brazilian patients and compare results with Latin America (LatAm) and World data.
The insulin Injection Technique Questionnaire (ITQ) survey consisted of an initial patient section (questions applied by an experienced nurse), followed by observation of injection technique and examination of the injection sites by the health care professional.
In Brazil, 255 patients were evaluated: 25% had type 1 diabetes mellitus (T1DM) and 75% had T2DM. In this study, 79% of patients injected less than 4 times a day, and 17.3% used insulin pens, compared to 28% in LatAm and 86% worldwide. Syringes were used by 78% of patients in Brazil, compared to 65% in LatAm and 10% globally. Differences in needle length were substantial-nearly 64% in Brazil inject with 8 mm length needle compared to 48% in LatAm and 27% worldwide. Additionally, 48% of patients in Brazil skip doses, 80% reuse pen needles and 57% reuse syringes with 27% having lipohypertrophy by exam.
Brazilian patients use syringes more and pens less, inject with larger needles and have more lipohypertrophy when compared to Latin America and World data. Their re-use of needles and syringes is also high. This study showed that in Brazil, teaching of proper injection technique has to be more widespread, and more intensive during diabetes educational sessions, and the type of delivered supplies must be updated to smaller, shorter needles preferred by patients, in order to facilitate adherence to treatment. From the ITQ, we conclude that there are many aspects of insulin injection technique that may be improved in Brazil.
2014 - 2015年,针对使用胰岛素的糖尿病患者开展了最大规模的国际胰岛素注射技术调查,涉及42个国家,共13289名参与者。在巴西,纳入了来自五个公共卫生中心的患者。本研究旨在评估巴西患者的胰岛素注射技术,并将结果与拉丁美洲(LatAm)和全球数据进行比较。
胰岛素注射技术问卷(ITQ)调查包括初始患者部分(由经验丰富的护士提出问题),随后由医护人员观察注射技术并检查注射部位。
在巴西,对255名患者进行了评估:25%患有1型糖尿病(T1DM),75%患有2型糖尿病(T2DM)。在本研究中,79%的患者每天注射少于4次,17.3%使用胰岛素笔,相比之下,拉丁美洲为28%,全球为86%。巴西78%的患者使用注射器,拉丁美洲为65%,全球为10%。针头长度差异显著——巴西近64%的患者使用8毫米长的针头注射,而拉丁美洲为48%,全球为27%。此外,巴西48%的患者会漏服剂量,80%重复使用笔式针头,57%重复使用注射器,经检查27%有脂肪增生。
与拉丁美洲和全球数据相比,巴西患者更多使用注射器,更少使用胰岛素笔,使用更大的针头注射,且脂肪增生更多。他们对针头和注射器的重复使用也很普遍。本研究表明,在巴西,正确注射技术的教学必须更广泛,在糖尿病教育课程中更深入,并且所提供用品的类型必须更新为患者更喜欢的更小、更短的针头,以促进治疗依从性。从ITQ中我们得出结论,巴西胰岛素注射技术在许多方面可能需要改进。